These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38217595)

  • 1. The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
    Safieh M; Liraz O; Ovadia M; Michaelson D
    J Alzheimers Dis; 2024; 97(2):753-775. PubMed ID: 38217595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.
    Gilat-Frenkel M; Boehm-Cagan A; Liraz O; Xian X; Herz J; Michaelson DM
    Curr Alzheimer Res; 2014; 11(6):549-57. PubMed ID: 24251389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
    Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.
    Salomon-Zimri S; Glat MJ; Barhum Y; Luz I; Boehm-Cagan A; Liraz O; Ben-Zur T; Offen D; Michaelson DM
    J Alzheimers Dis; 2016 Jun; 53(4):1443-58. PubMed ID: 27372644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.
    Rawat V; Wang S; Sima J; Bar R; Liraz O; Gundimeda U; Parekh T; Chan J; Johansson JO; Tang C; Chui HC; Harrington MG; Michaelson DM; Yassine HN
    J Neurosci; 2019 Nov; 39(48):9611-9622. PubMed ID: 31641056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
    Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
    Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice.
    Larramona-Arcas R; González-Arias C; Perea G; Gutiérrez A; Vitorica J; García-Barrera T; Gómez-Ariza JL; Pascua-Maestro R; Ganfornina MD; Kara E; Hudry E; Martinez-Vicente M; Vila M; Galea E; Masgrau R
    Mol Neurodegener; 2020 Jun; 15(1):35. PubMed ID: 32517777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
    Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
    J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3.
    Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L
    Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation.
    Valencia-Olvera AC; Balu D; Faulk N; Amiridis A; Wang Y; Pham C; Avila-Munoz E; York JM; Thatcher GRJ; LaDu MJ
    Neurotherapeutics; 2023 Jul; 20(4):1120-1137. PubMed ID: 37157042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4.
    Oue H; Yamazaki Y; Qiao W; Yuanxin C; Ren Y; Kurti A; Shue F; Parsons TM; Perkerson RB; Kawatani K; Wang N; Starling SC; Roy B; Mosneag IE; Aikawa T; Holm ML; Liu CC; Inoue Y; Sullivan PM; Asmann YW; Kim BY; Bu G; Kanekiyo T
    JCI Insight; 2023 Apr; 8(7):. PubMed ID: 37036005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of apolipoproteins E3 and E4 on the transforming growth factor-β system in targeted replacement mice.
    Haas A; Liraz O; Michaelson DM
    Neurodegener Dis; 2012; 10(1-4):41-5. PubMed ID: 22301441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice.
    Carter AY; Letronne F; Fitz NF; Mounier A; Wolfe CM; Nam KN; Reeves VL; Kamboh H; Lefterov I; Koldamova R
    PLoS One; 2017; 12(2):e0172161. PubMed ID: 28241068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines.
    Sepulveda J; Luo N; Nelson M; Ng CAS; Rebeck GW
    J Neurochem; 2022 Nov; 163(3):247-259. PubMed ID: 35838553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4.
    Rai A; Ojiakor OA; Rylett RJ
    J Neurochem; 2023 Aug; 166(3):572-587. PubMed ID: 37415276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.